DCs treated with EVs loaded with chaperone-enriched glioma lysate promoted the proliferation of CD4+ and CD8+ T cells and the activation of anti-tumor CTLs ex vivo, as well as the significant inhibition of tumor growth and prolonged survival of tumor-bearing mice. The gene discussed is CD4; the disease is neoplasm.